RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,136,494 | +17.9% | 135,136 | +76.1% | 0.00% | 0.0% |
| Q2 2023 | $963,666 | -42.7% | 76,725 | -24.9% | 0.00% | -50.0% |
| Q1 2023 | $1,682,838 | +10.2% | 102,176 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,526,509 | -31.0% | 102,176 | +3.2% | 0.00% | -33.3% |
| Q3 2022 | $2,213,779 | +359.3% | 98,962 | +244.0% | 0.00% | +200.0% |
| Q2 2022 | $482,000 | -39.5% | 28,772 | +8.1% | 0.00% | -50.0% |
| Q1 2022 | $797,000 | +4.7% | 26,620 | +7.4% | 0.00% | +100.0% |
| Q4 2021 | $761,000 | +5.3% | 24,787 | +8.1% | 0.00% | 0.0% |
| Q3 2021 | $723,000 | -13.8% | 22,921 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $839,000 | +22.3% | 22,921 | +15.5% | 0.00% | +100.0% |
| Q1 2021 | $686,000 | +17.9% | 19,845 | +41.8% | 0.00% | 0.0% |
| Q4 2020 | $582,000 | +33.8% | 13,996 | +37.0% | 0.00% | 0.0% |
| Q3 2020 | $435,000 | – | 10,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |